Cardinal “Fee-For-Service” Model Includes Rx Product Integrity Payments

Cardinal expects drug manufacturers to pay the drug wholesaler for maintaining "product integrity" as part of its new "fee-for-service" business model

More from Archive

More from Pink Sheet